Deutsche Bank’s aTyr Pharma ATYR Stock Holding History

Deutsche Bank’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-103,326	Closed	-$80.6K	–	3866
2026 Q1	$80.6K	Sell	103,326 -17,015	-14%	-$14.4K	﹤0.01%	3347
2025 Q4	$93.9K	Buy	120,341 +117,239	+3,779%	+$96.2K	﹤0.01%	3310
2025 Q3	$2.23K	Sell	3,102 -57,194	-95%	-$259K	﹤0.01%	3562
2025 Q2	$306K	Buy	+60,296	New	+$237K	﹤0.01%	2720
2018 Q2	–	Sell	-7,829	Closed	-$290K	–	5648
2018 Q1	$290K	Buy	7,829 +3,758	+92%	+$176K	﹤0.01%	4009
2017 Q4	$199K	Buy	+4,071	New	+$250K	﹤0.01%	4034
2016 Q4	–	Sell	-3,739	Closed	-$166K	–	5097
2016 Q3	$166K	Buy	3,739 +2,593	+226%	+$112K	﹤0.01%	3738
2016 Q2	$44K	Buy	1,146 +810	+241%	+$37.7K	﹤0.01%	4475
2016 Q1	$18K	Buy	336 +230	+217%	+$17.5K	﹤0.01%	4667
2015 Q4	$13K	Sell	106 -13	-11%	-$1.85K	﹤0.01%	4870
2015 Q3	$17K	Buy	119 +15	+14%	+$3.42K	﹤0.01%	4823
2015 Q2	$26K	Buy	+104	New	+$32.3K	﹤0.01%	4840

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank's ATYR Position: Q2 2026 in Review

Deutsche Bank sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 103,326 shares — an estimated $80.6K sold.

Deutsche Bank first reported a position in ATYR in Q2 2015 and held it in 12 quarters. The position peaked at $306K in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Deutsche Bank reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
Deutsche Bank sold 103,326 aTyr Pharma shares in Q2 2026, an estimated $80.6K.
Deutsche Bank first reported a position in aTyr Pharma in Q2 2015 and held it in 12 quarters.
Deutsche Bank's aTyr Pharma position peaked at $306K in Q2 2025.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.